Transcripts Nektar Therapeutics

Equities

NKTR

US6402681083

Real-time Estimate Cboe BZX Other stock markets 10:21:32 2024-04-30 am EDT			5-day change	1st Jan Change
1.485 ^USD	+1.71%		+3.93%	+161.20%

Apr. 24	Biolojic Design Announces Nektar Therapeutics Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases	CI
Mar. 19	Nektar Therapeutics announced that it has received $30 million in funding from TCG Crossover Management, LLC	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Nektar Therapeutics, Q4 2023 Earnings Call, Mar 04, 2024	Mar. 04
Transcript : Nektar Therapeutics Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 05:15 PM	Jan. 10
Transcript : Nektar Therapeutics, Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Transcript : Nektar Therapeutics - Special Call	23-09-13
Transcript : Nektar Therapeutics, Q2 2023 Earnings Call, Aug 08, 2023	23-08-08
Transcript : Nektar Therapeutics Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 01:20 PM	23-06-14
Transcript : Nektar Therapeutics, Q1 2023 Earnings Call, May 09, 2023	23-05-09
Transcript : Nektar Therapeutics - Special Call	23-02-23
Transcript : Nektar Therapeutics Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 08:15 AM	23-01-11
Transcript : Nektar Therapeutics - Shareholder/Analyst Call	22-12-12
Transcript : Nektar Therapeutics, Q3 2022 Earnings Call, Nov 03, 2022	22-11-03
Nektar Therapeutics Provides Earnings Guidance for the Year 2022	22-08-04	CI
Transcript : Nektar Therapeutics, Q2 2022 Earnings Call, Aug 04, 2022	22-08-04
Transcript : Nektar Therapeutics - Special Call	22-04-25
Transcript : Nektar Therapeutics - Shareholder/Analyst Call	22-03-14
Nektar Therapeutics Provides Revenue Guidance for the Full Year 2022	22-02-28	CI
Transcript : Nektar Therapeutics, Q4 2021 Earnings Call, Feb 28, 2022	22-02-28
Transcript : Nektar Therapeutics Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 03:00 PM	22-01-11
Transcript : Nektar Therapeutics - Shareholder/Analyst Call	21-12-06
Transcript : Nektar Therapeutics - Special Call	21-11-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Nektar Therapeutics

Equities

NKTR

US6402681083

Transcripts

Filters